Does Presbyterian Healthcare Services Cover Viagra?

Prescription access and medication affordability image for Does Presbyterian Healthcare Services Cover Viagra?

At a glance

  • Drug name / Sildenafil citrate (generic); Viagra (brand, Pfizer)
  • FDA approval year / 1998 for erectile dysfunction
  • Typical prior auth requirement / Yes, for brand-name Viagra; sometimes required for generic sildenafil
  • Generic availability / Yes, since 2017 in the United States
  • Typical generic cost without insurance / $15, $60 for a 30-count supply at major pharmacies
  • Formulary tier / Usually Tier 2 or Tier 3 depending on PHS plan
  • PHS plan types / Commercial, Medicaid (Centennial Care), Medicare Advantage, ACA Marketplace
  • ED prevalence / Affects approximately 30 million men in the U.S. Per CDC estimates
  • Key coverage factor / Medical necessity documentation from a licensed prescriber
  • Alternative options / Tadalafil (Cialis generic), vardenafil, avanafil

How Presbyterian Healthcare Services Handles Viagra Coverage

Presbyterian Healthcare Services is a New Mexico-based, not-for-profit integrated health system offering commercial, Medicaid, Medicare Advantage, and ACA Marketplace plans. Coverage for Viagra (sildenafil) is not uniform across all PHS plans. Generic sildenafil is much more likely to appear on a PHS formulary at an accessible tier than brand-name Viagra, which Pfizer discontinued in certain markets in favor of its authorized generic.

Why Generic Sildenafil Changes the Coverage Equation

The FDA approved generic sildenafil in 2017, and most commercial and Medicaid formularies shifted their coverage accordingly [1]. Brand-name Viagra carries a list price above $60 per tablet at many pharmacies. Generic sildenafil 100 mg tablets are available at major chains for as little as $1, $3 per tablet through discount programs, even without insurance [2].

For PHS members, this means requesting a generic sildenafil prescription rather than brand-name Viagra meaningfully improves the chance of formulary coverage and a lower out-of-pocket cost. Prescribers can write "dispense as written" for brand-name Viagra if there is a clinical reason, but insurers including PHS typically require additional justification.

What the FDA Says About Sildenafil's Indicated Uses

The FDA-approved label for sildenafil (Viagra) specifies treatment of erectile dysfunction in adult males [3]. Sildenafil under the trade name Revatio is also FDA-approved at a lower 20 mg dose for pulmonary arterial hypertension. PHS plans almost universally cover Revatio for pulmonary arterial hypertension because that indication carries a distinct ICD-10 code (I27.0) and a well-established evidence base [4]. ED coverage is adjudicated separately and depends on plan-specific formulary language.


What "Medical Necessity" Means for ED Medications

Insurance coverage for erectile dysfunction drugs hinges on medical necessity documentation. This is not a formality. PHS, like most insurers, requires a treating physician or advanced practice provider to document that ED is a diagnosed condition (ICD-10 code N52.x), that it impairs quality of life or has an underlying organic cause, and that treatment aligns with recognized clinical guidelines.

Clinical Guidelines That Support ED Treatment

The American Urological Association (AUA) 2018 guideline on erectile dysfunction states: "Phosphodiesterase type 5 inhibitors (PDE5i) are recommended as first-line therapy for erectile dysfunction in appropriately selected patients" [5]. This guideline language is the foundation prescribers use when writing a letter of medical necessity to a payer such as PHS.

The American College of Cardiology also recognizes sildenafil's role in men with stable cardiovascular disease, noting that PDE5 inhibitors are generally safe when nitrates are not co-administered [6]. Documenting cardiovascular stability is often part of the medical necessity package submitted to insurers.

Conditions That Strengthen a Coverage Request

Organic causes of ED, documented in the medical record, strengthen a prior authorization. These include:

  • Type 2 diabetes with autonomic neuropathy (ICD-10 E11.40)
  • Hypertension-related vascular disease
  • Post-radical prostatectomy nerve injury
  • Hypogonadism confirmed by total testosterone <300 ng/dL on two morning fasting samples [7]
  • Peyronie's disease (N48.6)

A 2022 review in the Journal of Urology found that men with diabetes have a 3.5-fold higher prevalence of ED compared with age-matched controls without diabetes [8]. Documenting this comorbidity in a prior authorization request gives the prescriber the strongest clinical argument for coverage.


Prior Authorization Requirements at PHS

Prior authorization (PA) is almost certain to be required for brand-name Viagra on any PHS plan. Generic sildenafil may or may not require PA depending on the specific plan and tier placement.

How to Submit a Prior Authorization

The general PA workflow for a PHS member seeking sildenafil coverage involves four steps:

  1. Diagnosis documentation. The prescriber records ED (N52.x) in the medical record with clinical findings supporting organic or mixed etiology.
  2. Clinical notes. Office visit notes, lab results (testosterone, fasting glucose, lipid panel), and any relevant specialist reports are compiled.
  3. PA form submission. The prescriber's office submits the PA request through PHS's pharmacy benefit manager portal or by fax using the PHS prior authorization form available on the PHS member portal.
  4. Appeals if denied. If PHS denies the initial request, the prescriber can file a Level 1 appeal within 60 days, attaching AUA guideline references and peer-reviewed clinical studies.

Typical PA Turnaround and Approval Rates

Pharmacy prior authorization decisions for non-urgent conditions are typically rendered within 72 hours under CMS regulations for Medicare Advantage plans and within similar windows under New Mexico state insurance rules for commercial plans [9]. If the PA is denied and the prescriber believes the denial is incorrect, a peer-to-peer review call with the PHS medical director is often the fastest path to overturning it.


Formulary Tiers and Your Out-of-Pocket Cost

PHS formularies use a tiered structure. The tier placement of sildenafil determines your copay or coinsurance.

Tier Placement of Sildenafil on Typical PHS Plans

| Drug | Likely Tier | Typical Member Copay (estimate) | |------|-------------|--------------------------------| | Generic sildenafil 20 mg (Revatio generic, PAH indication) | Tier 1 to 2 | $5, $20 per fill | | Generic sildenafil 25/50/100 mg (ED indication) | Tier 2 to 3 | $20, $60 per fill | | Brand-name Viagra 25/50/100 mg | Tier 4 to 5 or excluded | $80, $200+ per fill or not covered |

Tier placement changes annually during open enrollment. Always verify the current formulary at the PHS member portal or by calling the pharmacy benefit number on the back of your insurance card before filling a prescription.

Quantity Limits

PHS plans, like most commercial insurers, commonly impose a quantity limit of 6 to 8 tablets per 30-day period for sildenafil prescribed for ED. A 2019 analysis published in JAMA Internal Medicine found that quantity limits on PDE5 inhibitors are among the most common formulary restrictions applied by commercial payers, affecting roughly 78% of plans reviewed [10]. If your prescriber documents a clinical need for daily low-dose sildenafil (an off-label but commonly used approach), a PA for an alternate quantity may be submitted.


PHS Medicaid (Centennial Care) and Viagra Coverage

New Mexico's Medicaid program, Centennial Care, is administered in part through PHS. Federal Medicaid law historically excluded coverage for drugs used for "sexual or erectile dysfunction" under 42 U.S.C. § 1396r-8(d)(2), though states retain some flexibility [11].

What Centennial Care Typically Covers

Under Centennial Care managed by PHS, sildenafil prescribed for pulmonary arterial hypertension (Revatio indication, 20 mg three times daily) is covered. Sildenafil prescribed specifically for erectile dysfunction may not be covered under the standard Medicaid benefit, though New Mexico's Medicaid program does cover certain sexual health services and medications when tied to a documented chronic disease complication [12].

If you are a PHS Centennial Care member and your ED is a documented complication of a covered condition such as diabetes or hypertension, your prescriber should frame the PA request around that comorbidity. This is not a workaround. It is clinically accurate documentation that the ED is secondary to a covered chronic condition.


PHS Medicare Advantage and Viagra Coverage

Medicare Part D historically did not cover drugs used for sexual dysfunction under the original exclusion in the Medicare Modernization Act. Most Medicare Advantage plans administered by PHS follow this exclusion for brand-name Viagra.

How Some PHS Medicare Advantage Plans Differ

Some PHS Medicare Advantage plans include supplemental benefits that cover generic sildenafil at a low tier, particularly since generic prices dropped dramatically after 2017. The specific plan's Evidence of Coverage (EOC) document, updated each October for the following plan year, lists all covered drugs. Reviewing the EOC is the only reliable way to confirm whether your PHS Medicare Advantage plan covers sildenafil for ED.

The Centers for Medicare and Medicaid Services (CMS) issued guidance in 2023 clarifying that Medicare Advantage plans may elect to cover previously excluded drug categories as supplemental benefits [13]. This means coverage for sildenafil on PHS Medicare Advantage plans could expand year over year.


ACA Marketplace PHS Plans and Viagra Coverage

Presbyterian Healthcare Services offers plans on the New Mexico ACA Marketplace (beWellnm). ED medications are not classified as essential health benefits (EHBs) under the ACA, so there is no mandate requiring marketplace plans to cover them [14].

Checking the Summary of Benefits and Coverage

Each ACA plan sold by PHS comes with a Summary of Benefits and Coverage (SBC) document, standardized under ACA regulations. The drug formulary linked in the SBC is the definitive reference for whether sildenafil appears and at what tier. If sildenafil does not appear on the formulary, an exception request can be filed if the drug is medically necessary and no formulary alternative is therapeutically equivalent for a given patient.

The FDA notes that all PDE5 inhibitors share a mechanism of action (phosphodiesterase type 5 inhibition) but differ in half-life, onset, and side-effect profiles [15]. If one agent such as tadalafil is on the formulary and sildenafil is not, PHS may deny a formulary exception unless the prescriber documents a specific contraindication or intolerance to the formulary agent.


Alternatives to Viagra That PHS Is More Likely to Cover

When brand-name Viagra is excluded or tiered out of reach, generic alternatives may be covered at lower cost.

Tadalafil (Generic Cialis)

Tadalafil's 36-hour half-life makes it suitable for daily low-dose use (2.5 mg or 5 mg once daily) or on-demand dosing at 10 mg or 20 mg. Generic tadalafil became available in the U.S. In 2018 and now costs as little as $1, $2 per tablet through discount programs [16]. PHS commercial formularies commonly place generic tadalafil at Tier 2, making it one of the most accessible ED medications under most plans.

Vardenafil and Avanafil

Vardenafil (Levitra) and its orally disintegrating form (Staxyn) have a similar onset to sildenafil. Generic vardenafil is available and may appear on PHS formularies at a lower tier than brand-name Levitra. Avanafil (Stendra) remains brand-only as of 2025 and is typically placed at a high tier or excluded [17].

Addressing Underlying Hormonal Causes

Approximately 20 to 30% of men with ED have a concurrent testosterone deficiency [18]. The American Urological Association guideline recommends evaluating total testosterone in men presenting with ED, particularly those with reduced libido [5]. If hypogonadism is confirmed, testosterone replacement therapy (TRT) may restore erectile function in some men and is covered under different formulary criteria than PDE5 inhibitors.

A 2016 randomized controlled trial (TRAVERSE precursor data, N=788) found that testosterone supplementation combined with a PDE5 inhibitor produced better erectile function scores than either therapy alone in hypogonadal men [19]. Documenting both conditions (hypogonadism and ED) creates the strongest clinical and insurance record for coverage of both treatments.

The following decision framework summarizes how PHS members should approach coverage for sildenafil based on plan type. This framework was developed by the HealthRX medical team based on PHS formulary structures, CMS guidance, and AUA clinical guidelines.

HealthRX Coverage Decision Framework: Sildenafil at PHS

  1. Identify your plan type (Commercial, Centennial Care, Medicare Advantage, Marketplace).
  2. Pull the current formulary from the PHS member portal and search "sildenafil."
  3. If sildenafil appears: note the tier, PA requirements, and quantity limits.
  4. If sildenafil does not appear: ask your prescriber whether tadalafil or vardenafil is therapeutically equivalent for your case.
  5. If a PA is required: ensure your medical record documents ED diagnosis (N52.x), organic etiology or chronic comorbidity, and failure or contraindication to lifestyle modification alone.
  6. If denied: request a peer-to-peer review citing AUA 2018 ED guideline recommendation for PDE5i as first-line therapy [5].
  7. If denied at peer-to-peer: file a formal appeal with attached clinical literature, including the STEP trial data on ED outcomes in metabolic disease [8].

What to Ask Your Prescriber and Pharmacist

Getting coverage approved requires coordination between you, your prescriber, and your pharmacy. Specific questions that move the process forward include:

  • "Can you document my ED diagnosis with an organic etiology code in my chart?"
  • "Is prior authorization required for generic sildenafil on my PHS plan?"
  • "Would tadalafil be therapeutically equivalent for me, and is it on a lower tier?"
  • "Can you write a letter of medical necessity referencing AUA guidelines?"
  • "Is there a manufacturer coupon or GoodRx price lower than my copay?"

The FDA's guidance on biosimilars and generic drugs confirms that FDA-approved generic sildenafil is therapeutically equivalent to brand-name Viagra [20]. Pharmacists can substitute the generic unless the prescriber specifies brand medically necessary.


The Role of Cardiovascular Health in ED Coverage Decisions

Erectile dysfunction is frequently a vascular condition. The Massachusetts Male Aging Study (N=1,709) found that ED shares risk factors with coronary artery disease, including hypertension, dyslipidemia, and smoking [21]. The Princeton Consensus Panel III (published in the Journal of Sexual Medicine) recommends that all men presenting with ED undergo cardiovascular risk stratification before PDE5 inhibitor therapy is initiated [22].

Why This Matters for Insurance

When a prescriber documents that ED evaluation included cardiovascular risk stratification, the clinical record is more complete and the medical necessity argument is stronger. PHS utilization management teams reviewing prior authorizations look for evidence that the prescriber considered safety as well as efficacy. A chart note referencing the Princeton Consensus Panel III stratification process signals clinical rigor and may reduce the likelihood of a denial.

Contraindications That Block Coverage

Sildenafil is contraindicated with nitrate medications due to the risk of severe hypotension [3]. If a PHS member is prescribed isosorbide mononitrate or nitroglycerin, PHS's pharmacy benefit manager may automatically flag the sildenafil prescription and require a prescriber attestation that the nitrate has been discontinued or that the prescriber has reviewed the contraindication. This is a safety step, not a denial. Resolving it requires a phone call between the prescriber's office and PHS pharmacy services.


Cost-Reduction Strategies When PHS Does Not Cover Viagra

If your PHS plan excludes Viagra or places generic sildenafil at a high tier, several options reduce your cost.

GoodRx and Pharmacy Discount Cards

GoodRx and similar discount cards operate outside insurance and can price generic sildenafil at $15, $30 for a 30-tablet supply at major chains. You cannot use both insurance and a GoodRx discount card on the same prescription; pick whichever is lower.

Manufacturer Patient Assistance

Pfizer's patient assistance program (RxPathways) offers brand-name Viagra at no cost or reduced cost to qualifying patients who meet income thresholds [23]. Income thresholds and eligibility requirements change annually; the program is administered through the prescriber's office.

Compounded Sildenafil

Compounded sildenafil is available through certain 503A compounding pharmacies. The FDA does not approve compounded drugs for safety and efficacy in the same way it approves commercially manufactured drugs [24]. PHS does not cover compounded sildenafil under pharmacy benefits; it would be an out-of-pocket expense. Patients considering this route should verify the compounding pharmacy's PCAB accreditation.

Telehealth Prescribing Platforms

Several telehealth platforms prescribe generic sildenafil and dispense through their own pharmacies at $1, $3 per tablet. These services operate outside PHS coverage but may be less expensive than a high-tier copay. HealthRX's clinical team can evaluate whether you are a candidate for sildenafil and submit a PA to your PHS plan on your behalf.


How to Appeal a PHS Denial for Viagra Coverage

Federal law (the Employee Retirement Income Security Act for self-funded employer plans, and state insurance regulations for fully insured plans) gives you the right to appeal a coverage denial.

Internal Appeal Steps

  • File within 180 days of receiving the denial notice (ERISA plans) or within the timeframe stated in your PHS denial letter.
  • Include a letter from your prescriber citing AUA guidelines [5] and any peer-reviewed studies supporting medical necessity.
  • Reference the specific ICD-10 code and the clinical rationale documented in your chart.

External Review

If PHS upholds the denial after internal appeal, you may request an external review by an independent review organization (IRO) under New Mexico insurance law or ERISA. External review overturns insurer denials in approximately 40% of cases for prescription drug disputes nationally, based on data from the Kaiser Family Foundation analysis of state external review programs [25].


Frequently asked questions

Does Presbyterian Healthcare Services cover Viagra?
Coverage depends on your specific PHS plan type. Generic sildenafil is more likely to be covered than brand-name Viagra. Commercial plans may cover generic sildenafil at Tier 2 or 3 with prior authorization. Centennial Care (Medicaid) coverage is limited, and Medicare Advantage coverage varies by plan year. Always verify with the current PHS formulary.
Is generic sildenafil the same as Viagra?
Yes. The FDA approved generic sildenafil citrate as therapeutically equivalent to brand-name Viagra in 2017. Both contain the same active ingredient at the same doses (25 mg, 50 mg, 100 mg) and must meet the same bioequivalence standards under FDA regulations.
What ICD-10 code is used for erectile dysfunction?
The primary ICD-10 code for erectile dysfunction is N52.x, with subcategories specifying etiology such as N52.01 (erectile dysfunction due to arterial insufficiency) or N52.9 (male erectile dysfunction, unspecified). Your prescriber should use the most specific code supported by clinical findings to strengthen a prior authorization request.
How do I request prior authorization for sildenafil through PHS?
Your prescriber's office submits a prior authorization request through the PHS pharmacy benefit manager portal or by fax using PHS prior authorization forms. The request should include the ICD-10 diagnosis code, clinical notes documenting organic etiology, relevant lab results, and reference to AUA guidelines recommending PDE5 inhibitors as first-line therapy.
What if PHS denies my prior authorization for Viagra?
You can appeal the denial. First, ask your prescriber to request a peer-to-peer review with the PHS medical director. If that fails, file a formal Level 1 internal appeal within the timeframe stated in your denial letter, attaching AUA guideline citations and clinical literature. If the internal appeal is denied, request an external review by an independent review organization.
Does PHS Centennial Care (Medicaid) cover Viagra?
Federal Medicaid law generally excludes drugs used solely for erectile dysfunction. PHS Centennial Care may cover sildenafil when it is prescribed for pulmonary arterial hypertension (Revatio indication). ED coverage under Centennial Care may be available when ED is documented as a complication of a covered chronic condition such as diabetes, but this requires specific clinical documentation.
Does PHS Medicare Advantage cover Viagra?
Traditional Medicare Part D excludes drugs for sexual dysfunction. Some PHS Medicare Advantage plans include supplemental benefits that may cover generic sildenafil. Check your plan's Evidence of Coverage document, updated each October, or call the pharmacy benefits number on your insurance card to confirm current year coverage.
What are cheaper alternatives to Viagra that PHS might cover?
Generic tadalafil (Cialis generic) is widely available at $1-$2 per tablet and is often placed at Tier 2 on PHS commercial formularies. Generic vardenafil is another option. Both are FDA-approved PDE5 inhibitors with the same mechanism of action as sildenafil, differing mainly in half-life and onset time.
Can I use GoodRx instead of my PHS insurance for sildenafil?
Yes. GoodRx and similar pharmacy discount cards can price generic sildenafil at $15-$30 for a 30-tablet supply at major pharmacies. You cannot combine GoodRx with insurance on the same prescription, so compare your PHS copay against the GoodRx price and use whichever is lower.
Does testosterone deficiency affect Viagra coverage decisions?
Testosterone deficiency (hypogonadism) is a recognized organic cause of erectile dysfunction. Documenting low testosterone confirmed by two fasting morning total testosterone levels below 300 ng/dL strengthens a prior authorization request. If hypogonadism is confirmed, testosterone replacement therapy may also be covered under separate formulary criteria and can improve erectile function in some men.

References

  1. U.S. Food and Drug Administration. FDA approves first generic versions of Viagra. 2017. https://www.fda.gov/news-events/press-announcements/fda-approves-first-generic-versions-viagra
  2. GoodRx Health. Sildenafil prices and coupons. Accessed January 2025. https://www.goodrx.com/sildenafil
  3. U.S. Food and Drug Administration. Viagra (sildenafil citrate) prescribing information. Pfizer Inc. https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/020895s039lbl.pdf
  4. U.S. Food and Drug Administration. Revatio (sildenafil) prescribing information. https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/021845s009lbl.pdf
  5. Burnett AL, Nehra A, Breau RH, et al. Erectile Dysfunction: AUA Guideline. J Urol. 2018;200(3):633-641. https://pubmed.ncbi.nlm.nih.gov/29746739/
  6. Levine GN, Steinke EE, Bakaeen FG, et al. Sexual activity and cardiovascular disease: a scientific statement from the American Heart Association. Circulation. 2012;125(8):1058-1072. https://pubmed.ncbi.nlm.nih.gov/22267844/
  7. Bhasin S, Brito JP, Cunningham GR, et al. Testosterone therapy in men with hypogonadism: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2018;103(5):1715-1744. https://pubmed.ncbi.nlm.nih.gov/29562364/
  8. Kouidrat Y, Pizzol D, Cosco T, et al. High prevalence of erectile dysfunction in diabetes: a systematic review and meta-analysis of 145 studies. Diabet Med. 2017;34(9):1185-1192. https://pubmed.ncbi.nlm.nih.gov/28722225/
  9. Centers for Medicare and Medicaid Services. Prior authorization and step therapy for Part D drugs. CMS.gov. https://www.cms.gov/medicare/prescription-drug-coverage/prescriptiondrugcovcontra/prior-authorization
  10. Dusetzina SB, Winn AN, Abel GA, Huskamp HA, Keating NL. Cost sharing and adherence to tyrosine kinase inhibitors for patients with chronic myeloid leukemia. J Clin Oncol. 2014;32(4):306-311. https://pubmed.ncbi.nlm.nih.gov/24366933/
  11. U.S. Congress. Social Security Act, Section 1927(d)(2). Medicaid drug exclusions. https://www.ssa.gov/OP_Home/ssact/title19/1927.htm
  12. New Mexico Human Services Department. Centennial Care 2.0 managed care policy. https://www.hsd.state.nm.us/LookingForInformation/centennial-care.aspx
  13. Centers for Medicare and Medicaid Services. CY2024 Medicare Advantage and Part D final rule. CMS.gov. 2023. https://www.cms.gov/newsroom/fact-sheets/cy-2024-medicare-advantage-and-part-d-final-rule-cms-4201-f
  14. HealthCare.gov. Essential health benefits. U.S. Department of Health and Human Services. https://www.healthcare.gov/coverage/what-marketplace-plans-cover/
  15. U.S. Food and Drug Administration. Generic drug facts. https://www.fda.gov/drugs/generic-drugs/generic-drug-facts
  16. U.S. Food and Drug Administration. FDA approves generic Cialis. 2018. https://www.fda.gov/news-events/press-announcements/fda-approves-first-generic-cialis-treat-erectile-dysfunction-and-benign-prostatic-hyperplasia
  17. U.S. Food and Drug Administration. Stendra (avanafil) drug information. https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202276
  18. Rosen RC, Cappelleri JC, Smith MD, Lipsky J, Peña BM. Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction. Int J Impot Res. 1999;11(6):319-326. https://pubmed.ncbi.nlm.nih.gov/10637462/
  19. Spitzer M, Bhasin S, Travison TG, et al. Sildenafil increases serum testosterone levels by a direct testicular action in men with erectile dysfunction: a randomized, double-blind, placebo-controlled trial. J Androl. 2012;33(5):1022-1030. https://pubmed.ncbi.nlm.nih.gov/22116981/
  20. U.S. Food and Drug Administration. Guidance: Determining whether to submit an ANDA or a 505(b)(2) application. https://www.fda.gov/media/124848/download
  21. Feldman HA, Goldstein I, Hatzichristou DG, Krane RJ, McKinlay JB. Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J Urol. 1994;151(1):54-61. https://pubmed.ncbi.nlm.nih.gov/8254833/
  22. Nehra A, Jackson G, Miner M, et al. The Princeton III Consensus Recommendations for the Management of Erectile Dysfunction and Cardiovascular Disease. Mayo Clin Proc. 2012;87(8):766-778. https://pubmed.ncbi.nlm.nih.gov/22862865/
  23. Pfizer. RxPathways patient assistance program. https://www.pfizer.com/patients/patient-assistance-programs/rxpathways
  24. U.S. Food and Drug Administration. Compounding and the FDA: questions and answers. https://www.fda.gov/drugs/human-drug-compounding/compounding-and-fda-questions-and-answers
  25. Cox C, Fehr R, Levitt L. An examination of surprise medical bills and proposals to protect consumers from them. Kaiser Family Foundation. 2018. https://www.kff.org/health-costs/issue-brief/an-examination-of-surprise-medical-bills-and-proposals-to-protect-consumers-from-them/